The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice.

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2355

Title:	The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice.
Authors:	Yocum, D Wolfe, F Rahman, MU Han, J Berman, A. Strusberg, I Westhovens, R GEUSENS, Piet
Issue Date:	2004
Publisher:	WILEY-LISS
Source:	ARTHRITIS AND RHEUMATISM, 50(9). p. S659-S659
Notes:	Univ Arizona, Tucson, AZ USA. Natl Data Bank Rheum Dis, Wichita, KS USA. Centocor Inc, Malvern, PA 19355 USA. Hosp Angel C Padilla, San Miguel De Tucuman, Argentina. Ctr Reumatol Strusberg, Cordoba, Argentina. Univ Hosp Maastricht, Maastricht, Netherlands. Limburgs Univ Ctr, Maastricht, Netherlands. UZ Gasthuisberg, Louvain, Belgium.
Document URI:	http://hdl.handle.net/1942/2355
ISSN:	0004-3591
ISI #:	000223799001828
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

Check